SHANGHAI, Jan. 15, 2024 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage ?a hepatocellular carcinoma at high risk of recurrence after surgical resection lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Carsgen's CT011 Achieves IND Clearance From The NMPA For The GPC3-Positive Stage Iiia Hepatocellular Carcinoma At High Risk Of Recurrence After Surgic... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.